U.S. markets open in 9 hours
  • S&P Futures

    4,131.75
    -21.75 (-0.52%)
     
  • Dow Futures

    32,948.00
    -207.00 (-0.62%)
     
  • Nasdaq Futures

    14,001.50
    -33.50 (-0.24%)
     
  • Russell 2000 Futures

    2,210.40
    -20.20 (-0.91%)
     
  • Crude Oil

    72.03
    +0.39 (+0.54%)
     
  • Gold

    1,774.30
    +5.30 (+0.30%)
     
  • Silver

    25.91
    -0.06 (-0.25%)
     
  • EUR/USD

    1.1862
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.4500
    -1.5110 (-100.00%)
     
  • Vix

    20.70
    -17.75 (-100.00%)
     
  • GBP/USD

    1.3796
    -0.0013 (-0.09%)
     
  • USD/JPY

    109.7800
    -0.3700 (-0.34%)
     
  • BTC-USD

    34,221.91
    -1,426.96 (-4.00%)
     
  • CMC Crypto 200

    846.27
    -93.68 (-9.97%)
     
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • Nikkei 225

    27,974.99
    -989.09 (-3.41%)
     

Zynerba: 4Q Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

DEVON, Pa. (AP) _ Zynerba Pharmaceuticals Inc. (ZYNE) on Monday reported a loss of $7.8 million in its fourth quarter.

The Devon, Pennsylvania-based company said it had a loss of 44 cents per share.

The specialty pharmaceutical company posted revenue of $86,000 in the period.

For the year, the company reported that its loss widened to $39.9 million, or $2.61 per share. Revenue was reported as $86,000.

The company's shares closed at $4.78. A year ago, they were trading at $9.14.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZYNE at https://www.zacks.com/ap/ZYNE